Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HUMANA INCHUM · Entity 1429 | Director | December 31, 2025 | January 05, 2026 |
| TheRealReal, Inc.REAL · Entity 4817 | Director | September 30, 2026 | October 02, 2026 |
| Under Armour, Inc.UA · Entity 558 | Director | July 01, 2025 | July 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HUMANA INC
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,627 |
Reported balance
After 2026-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-02 · Grant · Acquired 766 · Balance 3,627 F1: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 124 |
Reported balance
After 2025-12-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-12-31 · Grant · Acquired 49 · Balance 124 F3: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 535 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 535 F2: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). |
| Humana CommonSEC Table I · non-derivative | Direct | 590 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 590 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan
F2: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F3: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
TheRealReal, Inc.
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 256,145 |
Reported balance
After 2026-09-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 2,262 · Balance 256,145 F1: Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock. F2: The DRSUs were granted to the Reporting Person on September 30, 2026 pursuant to TheRealReal Inc. 2019 Equity Incentive Plan and are fully vested. The DRSUs are deferred and generally will be settled upon the Reporting Persons separation from service as a Non-Employee Director of the TheRealReal Inc. or a date elected by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.
F2: The DRSUs were granted to the Reporting Person on September 30, 2026 pursuant to TheRealReal Inc. 2019 Equity Incentive Plan and are fully vested. The DRSUs are deferred and generally will be settled upon the Reporting Persons separation from service as a Non-Employee Director of the TheRealReal Inc. or a date elected by the Reporting Person.
Under Armour, Inc.
Report date July 01, 2025 · Filed July 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class C Common StockSEC Table I · non-derivative | Direct | 188,479.75 |
Reported balance
After 2025-07-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-07-01 · Grant · Acquired 3,338.28 · Balance 188,479.75 F1: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan. |
| Class C Common StockSEC Table I · non-derivative | IndirectKatz Family Trust | 2,014 |
Reported balance
Holding disclosure · report date 2025-07-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,014 |
| Class A Common StockSEC Table I · non-derivative | Direct | 5,120.96 |
Reported balance
Holding disclosure · report date 2025-07-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,120.96 |
| Class A Common StockSEC Table I · non-derivative | IndirectKatz Family Trust | 2,000 |
Reported balance
Holding disclosure · report date 2025-07-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Casper Sleep Inc.
Report date January 25, 2022 · Filed January 26, 2022
Section 16 reporting ended · disclosed 2022-01-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-01-25 transaction · row 1
1 source rowRow 1 · 2022-01-25 · Disposition to issuer · Disposed 40,012 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes. F2: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $15.90 · Expires 2029-04-10 | Direct | 0 |
Reported balance
After 2022-01-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-01-25 · Disposition to issuer · Disposed 60,000 · Balance 0 F4: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F3: The options provided for vesting in equal monthly installments over a four year period commencing on May 11, 2019, and would have been fully vested and exercisable on April 11, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes.
F2: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award.
F3: The options provided for vesting in equal monthly installments over a four year period commencing on May 11, 2019, and would have been fully vested and exercisable on April 11, 2023.
F4: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2021 Filed Sep 14, 2021 21:20 UTC | TheRealReal, Inc. REAL · Entity 4817 | GrantCommon Stock | 9,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001573221-21-000154 · edgardoc.xml · nonDerivative · entry 1 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,230 Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:18 UTC | Casper Sleep Inc. CSPR · Entity 131068 | GrantCommon Stock | 1,284 | $8.27 | $10,618.68 |
DisclosureSEC source: 0001598674-21-000067 · wf-form4_162672586734589.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,048 F2 · shares: Represents 1,284 deferred stock units received in lieu of cash compensation for service as a director pursuant to an election made by the Reporting Person. Each deferred stock unit will settle in full 90 days after the Reporting Person ceases to serve on the Company's Board of Directors. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 20:21 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 1,263.3 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000814 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,710.83 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 15:30 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 66 | $442.72 | $29,219.19 |
DisclosureSEC source: 0000049071-21-000105 · edgar.xml · derivative · entry 3 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441 Underlying: Humana Common · 66 shares Expires not disclosed F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:43 UTC | Casper Sleep Inc. CSPR · Entity 131068 | GrantCommon Stock | 16,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001598674-21-000053 · wf-form4_162370700368934.xml · nonDerivative · entry 1 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,394 F1 · shares: Represents 16,062 deferred stock units. Each deferred stock unit represents a contingent right to receive one share of common stock. The deferred stock units will vest on the earlier of (i) the day immediately preceding the 2022 Annual Meeting of Stockholders and (ii) June 10, 2022 and, pursuant to an election made by the Reporting Person, will settle in full 90 days after the Reporting Person ceases to serve on the Company's Board of Directors. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:15 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 8,161.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000742 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,447.53 F1 · security: Annual restricted stock unit grant pursuant to the Under Armour, Inc. 2021 Non-Employee Director Compensation Plan. Read SEC document |
| April 29, 2021 Filed May 3, 2021 20:54 UTC | TheRealReal, Inc. REAL · Entity 4817 | GrantCommon Stock | 2,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001573221-21-000068 · primary_doc.xml · nonDerivative · entry 1 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,143 Read SEC document |
| April 15, 2021 Filed Jul 19, 2021 20:18 UTC | Casper Sleep Inc. CSPR · Entity 131068 | GrantCommon Stock | 1,370 | $7.75 | $10,617.50 |
DisclosureSEC source: 0001598674-21-000067 · wf-form4_162672586734589.xml · nonDerivative · entry 1 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,764 F1 · shares: Represents 1,370 deferred stock units received in lieu of cash compensation for service as a director pursuant to an election made by the Reporting Person. Each deferred stock unit will settle in full 90 days after the Reporting Person ceases to serve on the Company's Board of Directors. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:21 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 1,299.95 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000639 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,286.48 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 13:50 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 67 | $422.60 | $28,314.20 |
DisclosureSEC source: 0000049071-21-000070 · edgar.xml · derivative · entry 3 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Humana Common · 67 shares Expires not disclosed F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 19:42 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 403 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000006 · edgar.xml · derivative · entry 5 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403 Underlying: Humana Common · 403 shares Expires not disclosed F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/21. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/21. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/21. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/21. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:07 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 1,577.03 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000024 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,986.53 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 19:42 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 3 | $407.16 | $1,221.47 |
DisclosureSEC source: 0000049071-21-000006 · edgar.xml · derivative · entry 4 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3 Underlying: Humana Common · 3 shares Expires not disclosed F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 19:42 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 73 | $407.16 | $29,722.32 |
DisclosureSEC source: 0000049071-21-000006 · edgar.xml · derivative · entry 3 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308 Underlying: Humana Common · 73 shares Expires not disclosed F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:14 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 1,721.06 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-20-001589 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,409.5 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:47 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 71 | $410.09 | $29,116.57 |
DisclosureSEC source: 0000049071-20-000126 · edgar.xml · derivative · entry 3 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235 Underlying: Humana Common · 71 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| September 20, 2020 Filed Sep 22, 2020 13:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000124 · edgar.xml · derivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 590 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 09/20/2020 and forfeited in its entirety if service is less than one year. F2 · derivative.expiration_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 09/20/2020 and forfeited in its entirety if service is less than one year. Read SEC document |
| September 20, 2020 Filed Sep 22, 2020 13:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000124 · edgar.xml · nonDerivative · entry 1 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 11:30 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 2,059.31 | $0.00 | $0.00 |
DisclosureSEC source: 0001336917-20-000046 · primary_doc.xml · nonDerivative · entry 1 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,688.44 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:23 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 78 | $384.15 | $29,963.70 |
DisclosureSEC source: 0000049071-20-000097 · edgar.xml · derivative · entry 3 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164 Underlying: Humana Common · 78 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| May 27, 2020 Filed May 29, 2020 20:21 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 17,626.32 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-20-001342 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,629.13 F1 · security: Annual restricted stock unit grant pursuant to the Under Armour, Inc. 2019 Non-Employee Director Compensation Plan. Read SEC document |
| April 01, 2020 Filed Apr 1, 2020 21:28 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 3,187.92 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-20-000995 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,002.81 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 15:38 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 86 | $308.22 | $26,506.49 |
DisclosureSEC source: 0000049071-20-000074 · edgar.xml · derivative · entry 3 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86 Underlying: Humana Common · 86 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 21:35 UTC | Casper Sleep Inc. CSPR · Entity 131068 | GrantCommon Stock | 17,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-030850 · a4.xml · nonDerivative · entry 1 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,332 F1 · shares: The Reporting Person received an award of 17,332 restricted stock units on March 5, 2020. The restricted stock units vest in full on March 5, 2021. Each restricted stock unit represents a right to receive one share of Issuer common stock upon vesting. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 14:15 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 453 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000013 · edgar.xml · derivative · entry 3 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453 Underlying: Humana Common · 453 shares Expires not disclosed F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/20. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/20. Read SEC document |
| January 02, 2020 Filed Mar 6, 2020 21:07 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 974.53 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-20-000813 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,814.89 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:08 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 1,041.09 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002193 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,840.36 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| September 20, 2019 Filed Sep 24, 2019 14:22 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-19-000095 · edgar.xml · derivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590 Underlying: Humana Common · 590 shares Expires not disclosed F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 09/20/2020 and forfeited in its entirety if service is less than one year. F2 · derivative.expiration_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 09/20/2020 and forfeited in its entirety if service is less than one year. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:07 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 849.57 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-001660 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,799.27 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:35 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 7,649.16 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-001428 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,949.7 F1 · security: Annual restricted stock unit grant pursuant to the Under Armour, Inc. 2019 Non-Employee Director Compensation Plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:28 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 995.22 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-001177 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,300.54 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:08 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 1,139.82 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-000014 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,305.32 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:14 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 969.49 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-18-002310 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,165.5 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 12:42 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 886.52 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-18-001814 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,196.01 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| May 09, 2018 Filed May 10, 2018 20:07 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 9,085.4 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-18-001512 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,309.49 F1 · security: Annual restricted stock unit grant pursuant to the Under Armour, Inc. 2017 Non-Employee Director Compensation Plan. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 20:14 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 1,340.24 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-18-001231 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,224.09 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 22:56 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 1,342.16 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-18-000084 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,883.85 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 20:14 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 1,243.37 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002850 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,541.69 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 20:07 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 913.74 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002292 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,298.32 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 21:07 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 8,412.79 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002064 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,384.58 F1 · security: Annual restricted stock unit grant pursuant to the Under Armour, Inc. 2017 Non-Employee Director Compensation Plan. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 20:21 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 1,021.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001552 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,971.79 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:21 UTC | Under Armour, Inc. UA · Entity 558 | GrantClass C Common Stock | 727.87 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-000071 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,949.99 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:07 UTC | Under Armour, Inc. UAC · Entity 558 | GrantClass C Common Stock | 550.66 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-16-006899 · form.xml · nonDerivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,222.12 F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.